Literature DB >> 30405930

Nasal Chondromesenchymal Hamartoma: Rare Case Report in an Elderly Patient and Brief Review of Literature.

Kanish Mirchia1, Rana Naous1.   

Abstract

Hamartomas are considered a mixture of nonneoplastic tissue, which may be indigenous to a different location in the body. As such, they may be epithelial, mesenchymal, or mixed. In the sinonasal region, the following hamartomatous lesions are considered to lie on a spectrum and include respiratory epithelial adenomatoid hamartoma (REAH), chondro-osseous respiratory epithelial adenomatoid hamartoma (COREAH), and nasal chondromesenchymal hamartoma (NCMH). To our knowledge, less than 50 cases of sinonasal hamartomas have been reported in the English literature so far with NCMH being very rare and primarily a tumor in infancy, with only 2 cases reported in individuals older than 16 years of age. We report a highly unusual case of a NCMH in the right maxillary sinus of a 70-year-old female.

Entities:  

Year:  2018        PMID: 30405930      PMCID: PMC6204234          DOI: 10.1155/2018/5971786

Source DB:  PubMed          Journal:  Case Rep Pathol        ISSN: 2090-679X


1. Case Report

A 70-year-old female presented with a two-year history of slowly growing, nonpainful maxillary sinus mass. She has a history of chronic maxillary sinusitis corresponding to presentation of the mass, with the first episode reported in 2014. Computed tomography (CT) imaging revealed an erosive right maxillary sinus mass (2.5 x 2.1 cm) with bony destruction. Surgical excision of the right maxillary sinus mass revealed a fragmented, white, vaguely nodular, and whorled lesion. Histological examination revealed fragments of respiratory-type epithelium with focal cystic invagination and associated squamous metaplasia [Figure 1]. The underlying stroma consisted of a variably cellular, benign spindle cell proliferation with an associated background of hyalinization [Figure 2], calcification and ossification [Figure 3], and focal chondroid change [Figure 4] in a vague lobule-like arrangement. Focal areas of aneurysmal and cystic changes [Figure 5] were seen which would provide an explanation for the clinically noted enlargement since hamartomas by definition would be expected to have a much lower rate of growth. The intrinsic slow-growing nature is also supported by the deficit of mitotic activity even in the highly cellular/spindled regions of the lesion (less than 1/10 hpf). Areas with haphazard arrangement of nerve bundles within the collagenous stroma [Figure 6] were also noted. Immunohistochemical stains were positive for SMA [Figures 7(a) and 7(b)] in the spindle cells and negative for CK AE1/AE3, EMA, CD34, Stat6, ERG/FLI-1, Mucin 4, S-100, Sox-10, and desmin [Figure 8]; ruling out perineurioma, solitary fibrous tumor, a vascular neoplasm, Evans tumor, a benign peripheral nerve sheath tumor, or a myogenic neoplasm. The overall findings were suggestive of a hamartomatous lesion, most likely a nasal chondromesenchymal hamartoma. The absence of submucosal glandular proliferation, myxoid stroma, or mucinous metaplasia in the lining epithelium lowers the likelihood of other neoplastic hamartomatous lesions such as COREAH.
Figure 1

Area of respiratory lining epithelium with squamous metaplastic change (arrowheads).

Figure 2

Focal areas of stroma displaying hyalinization (arrowheads).

Figure 3

Focal areas displaying calcification and ossification surrounded by variably spindled stroma.

Figure 4

Chondroid regions which support the hamartomatous nature of the lesion. Inset shows area at low-power with spatial relation of components, including surface ciliated epithelium (∗) and bone (within dashed lines).

Figure 5

Variably dilated cystic regions within the lesion.

Figure 6

Disorganized bundles of nervous tissue interspersed within collagenous stroma.

Figure 7

Immunohistochemistry for smooth muscle actin (SMA) showing positive staining in the spindled lesional cells.

Figure 8

Lesional cells are negative for pan-cytokeratin (ae1/ae3), desmin, Sox-10, and S100. CD34 and ERG/FLI-1 highlight vascular endothelial cells.

2. Discussion

Nasal chondromesenchymal hamartomas are most commonly seen in the nasal cavity of children less than 3 months old, with less common involvement of the paranasal sinuses [2]. As per one review [1], mean age for NCMH was 9.6 years. Review of the English PubMed literature reveals 43 cases [Table 1] of NCMH previously published, with our case being the oldest patient reported, and presenting with a tumor in an unusual location.
Table 1

Brief review of cases of nasal chondromesenchymal hamartomas reported in the English literature. Some cases also reported in older review articles [1].

AgeSexFollow-up(Asymptomatic)SitePertinent InformationStudyYear
5 daysM2 yearsNasal cavity-[2] McDermott1998

12 daysF< 16 monthsNasal cavityIntracranial extension[2] McDermott1998

14 daysM-Nasal cavityEthmoid SinusIntracranial extensionResidual tumor[2] McDermott1998

2 monthsM18 monthsNasal cavityIntracranial extension[2] McDermott1998

3 monthsF2 yearsNasal cavityEthmoid SinusIntracranial extensionResidual tumor[2] McDermott1998

3 monthsM4 yearsNasal cavity-[2] McDermott1998

7 years M - Nasal cavity Sphenoid sinus PPB , multiple recurrences [2] McDermott 1998

4 monthsM13 yearsNasal cavityIntracranial extension[3] Kato1999

0 daysM5 yearsNasal cavitySphenoiod sinusEthmoid sinusOrbital compression[4] Hsueh2001

9 monthsM9 monthsNasal cavity-[4] Hsueh2001

16 years M 8 months Nasal cavity 3-month history [5] Alrawi M 2003

5 monthsM-Nasal cavityOrbital compression[6] Kim B2004

11 years M - Nasal cavity Ethmoid sinus 8-month history [7] Norman ES 2004

1 yearM-Nasal cavityOrbital extensionResidual tumor[8] Shet T2004

11 years M - Nasal cavity Ethmoid sinus - [9] Ozolek JA 2005

17 years F - Nasal cavity - [9] Ozolek JA 2005

25 years M - Nasal cavity Maxillary sinus Bilateral NCMHIntracranial aneurysms [9] Ozolek JA 2005

69 years F - Nasal cavity Ethmoid sinus - [9] Ozolek JA 2005

11 years M 2 months Nasal cavity - [10] Low SE 2006

15 years F 6 months Nasal cavity Bilateral NCMHPPB [11] Johnson C 2007

7 monthsM18 monthsNasal cavityOrbital compression[12] Silkiss RZ2007

12 monthsM-Nasal cavityOrbital compression[13] Finitsis S2009

19 monthsM10 monthsNasal cavityIntracranial, orbital extension[14] Kim JE2009

2 cases previously reported, both with PPB, multiple recurrences [15] Priest JR2010

10 years F 21 months Nasal cavity Bilateral NCMHPPB [15] Priest JR 2010

11 years M 4 months Nasal cavity PPB [15] Priest JR 2010

11 years M - - PPB [16] Behery RE 2012

8 years M 6 months Sphenoid sinus Ethmoid sinus 4-month history [17] Uzomefuna 2012

14 years M 4 years Nasal cavity Maxillary sinus - [18] Cho YC 2013

23 years M 3 months Nasal cavity Ethmoid Sinus Orbital extension [19] Li GY 2013

40 years F - Nasal cavity Ethmoid Sinus Maxillary sinus Malignant transformation Recurrence [20] Li Y 2013

9 monthsF-Nasal cavityMaxillary sinusOrbital compression[21] Moon S2014

14 years M - Nasal cavity Bilateral NCMHPPB [22] Obidan AA 2014

6 weeksF10 monthsNasal cavity-[23] Wang T2014

5 years M 3 years Nasal cavityEthmoid sinus 4-year history [23] Wang T 2014

10 monthsM18 monthsNasal cavity6-month history[24] Lee CH2015

49 years M 2 years4 years (phone) Nasal cavity 5-year history [1] Mason AK 2015

Systematic review[1] Mason AK2015

5 years M - Nasal cavity Previous rhabdomyosarcoma in remission [25] Avci H 2016

13 years F 12 months Nasal cavity 6-month history [26] Unal A 2016

3 yearsM3 yearsNasal cavity-[27] Nakaya M2017

Index. Cases older than 1 year of age at presentation. .

Our case would lend support to extending the age range for NCMH and considering it in the differential diagnosis of all sinonasal region tumors, irrespective of age, and location in the head and neck region. Despite primarily being a benign lesion, these tumors can present with areas of necrosis and local destruction, including bony invasion. The tumors can be aggressive appearing on imaging, extending into bony structures, including the cranium and/or the orbital cavity, which should not lead away from the diagnosis of this benign lesion. Detailed CT or preferably MRI prior to surgical excision should be performed. NCMH has been associated with development of pleuropulmonary blastoma (PPB) during infancy. A recent [28] report highlighted the association of NCMH and PPB with DICER1 mutation and various associated entities such as lung cysts, cystic nephroma, renal sarcoma, Wilms tumor, thyroid hyperplasia, and CNS tumors. NCMH in isolation however is a benign lesion with follow-up in patients up to 16 years after excision, except for one reported case with malignant transformation in the literature [20]. Etiologically, it would make sense that cases in adults, such as ours, represent a tissue response to insult, such as chronic sinusitis rather than an inborn germline error (such as a DICER1 mutation). Whether the presentation of a NCMH at a later age predisposes to malignant transformation due to the long-standing nature of the lesion is up for debate. It could represent a somatic DICER1 mutation rather than a germline mutation, causing the hamartoma to form later in age. Longer follow-up results from the adult cases and routine genetic testing in all NCMH will help provide an answer to these questions.

3. Conclusion

We report an unusual case of NCMH eroding the right maxillary sinus of a 70-year-old female. Although, NCMH is a rare entity with predilection for pediatric age groups, it is important to consider NCMH in the differential diagnosis of nasal/sinonasal masses in adult patients in order to avoid diagnostic errors.
  27 in total

1.  Nasal chondromesenchymal hamartoma with no nasal symptoms.

Authors:  Vincent Uzomefuna; Fergal Glynn; John Russell; Michael McDermott
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Nasal chondromesenchymal hamartoma: report of a case presenting with intraoral signs.

Authors:  Yeong Cheol Cho; Iel Yong Sung; Jang Ho Son; Robert Ord
Journal:  J Oral Maxillofac Surg       Date:  2012-06-12       Impact factor: 1.895

3.  Nasal chondromesenchymal hamartoma in an adolescent.

Authors:  S E Low; R K Sethi; E Davies; J S Stafford
Journal:  Histopathology       Date:  2006-09       Impact factor: 5.087

4.  Nasal chondromesenchymal hamartoma: CT and MR imaging findings.

Authors:  Ji-Eun Kim; Hyung-Jin Kim; Ji Hye Kim; Young-Hyeh Ko; Seung-Kyu Chung
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

Review 5.  Nasal chondromesenchymal hamartoma of infancy: the first Japanese case report.

Authors:  K Kato; R Ijiri; Y Tanaka; M Hara; K Sekido
Journal:  Pathol Int       Date:  1999-08       Impact factor: 2.534

6.  Nasal chondromesenchymal hamartoma: a rare nasal benign tumor.

Authors:  Hakan Avcı; Şenol Çomoğlu; Erkan Öztürk; Bilge Bilgiç; Ökkeş Erkan Kıyak
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2016 Sep-Oct

7.  Nasal chondromesenchymal hamartoma in children with pleuropulmonary blastoma--A report from the International Pleuropulmonary Blastoma Registry registry.

Authors:  John R Priest; Gretchen M Williams; William A Mize; Louis P Dehner; Michael B McDermott
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-09-06       Impact factor: 1.675

8.  Nasal chondromesenchymal hamartoma: radiographic and histopathologic analysis of a rare pediatric tumor.

Authors:  Craig Johnson; Usha Nagaraj; Jorge Esguerra; Daniel Wasdahl; Douglas Wurzbach
Journal:  Pediatr Radiol       Date:  2006-11-08

9.  Nasal chondromesynchymal hamartoma presenting in an adolescent.

Authors:  M Alrawi; M McDermott; D Orr; J Russell
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-06       Impact factor: 1.675

10.  DICER1 mutations in familial pleuropulmonary blastoma.

Authors:  D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow
Journal:  Science       Date:  2009-06-25       Impact factor: 47.728

View more
  4 in total

Review 1.  Pediatric Nasal Chondromesenchymal Tumors: Case Report and Review of the Literature.

Authors:  Daniel Schaerer; Javan Nation; Robert C Rennert; Adam DeConde; Michael L Levy
Journal:  Pediatr Neurosurg       Date:  2021-02-11       Impact factor: 1.162

2.  Transnasal endoscopic resection of nasal chondromesenchymal hamartoma in infancy: an analysis of 5 cases.

Authors:  Zheng Jie Zhu; Qi Huang; Lan Cheng; Jun Yang
Journal:  BMC Pediatr       Date:  2022-01-06       Impact factor: 2.125

3.  Nasal chondromesenchymal hamartomas in a cohort with pathogenic germline variation in DICER1.

Authors:  Lauren M Vasta; Alison Nichols; Laura A Harney; Ana F Best; Ann G Carr; Anne K Harris; Markku Miettinen; Kris Ann P Schultz; Hung Jeffrey Kim; Douglas R Stewart
Journal:  Rhinol Online       Date:  2020-04-13

Review 4.  THE "-OMAS" and "-OPIAS":  Targeted and Philosophical Considerations Regarding Hamartomas, Choristomas, Teratomas, Ectopias, and Heterotopias in Pediatric Otorhinolaryngologic Pathology.

Authors:  John A Ozolek; Merva Soluk Tekkesin
Journal:  Head Neck Pathol       Date:  2021-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.